2.57  -0.11 (-4.1%)		02-15 16:00
Open: 2.62 High: 2.64 Volume: 201,271		Pre. Close: 2.68 Low: 2.56 Market Cap: 53(M)

Short term
Mid term
Targets	6-month :	3.21	1-year :	3.35
Resists	First :	2.75	Second :	2.86
Pivot price	2.61
Supports	First :	2.55	Second :	2.12
MAs	MA(5) :	2.56	MA(20) :	2.63
	MA(100) :	2.46	MA(250) :	3.57
MACD	MACD :	-0.1	Signal :	-0.1
%K %D	K(14,3) :	3.5	D(3) :	3.4
RSI	RSI(14): 41
52-week	High :	6.51	Low :	1.46

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ EAR ] has closed above bottom band by 22.2%. Bollinger Bands are 59.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	2.57 - 2.58	2.58 - 2.6
Low:	2.54 - 2.55	2.55 - 2.57
Close:	2.55 - 2.57	2.57 - 2.59

Eargo, Inc., a medical device company, engages in enhancing the quality of life of people with hearing loss in the United States. The company markets and sells hearing aids. It sells its products direct-to-consumer and through omni-channel. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2014. Eargo, Inc. was incorporated in 2010 and is headquartered in San Jose, California.

Fri, 16 Feb 2024
Eargo Finalizes Major Merger and Exits NASDAQ - TipRanks.com - TipRanks

Thu, 15 Feb 2024
Eargo Hearing Aids Review (2024) – Forbes Health - Forbes

Wed, 14 Feb 2024
Eargo Stockholders Approve Merger with PSC Echo Parent LLC - TipRanks.com - TipRanks

Wed, 31 Jan 2024
Eargo Debuts Two New Devices, Expanding Portfolio of Hearing Wellness Offerings - Nasdaq

Wed, 31 Jan 2024
Eargo Debuts Two New OTC Hearing Devices - The Hearing Review

Tue, 19 Dec 2023
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into Eargo, Inc. - PR Newswire

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Devices
Shares Out	0 (M)
Shares Float	21 (M)
Held by Insiders	1.964e+007 (%)
Held by Institutions	5.4 (%)
Shares Short	12 (K)
Shares Short P.Month	0 (K)

EPS	-8.755e+007
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	-263.2 %
Operating Margin	-206.5 %
Return on Assets (ttm)	-60.1 %
Return on Equity (ttm)	-2 %
Qtrly Rev. Growth	4.111e+007 %
Gross Profit (p.s.)	3.1
Sales Per Share	308.83
EBITDA (p.s.)	0
Qtrly Earnings Growth	15 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	-75 (M)

PE Ratio	-0.01
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	1.75

Dividend	0
Forward Dividend	42080
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.